Ex-Rolls Royce | Ex-Airbus | Ex-Bayer | Intensifying mechanisation on farm fields with the utilisation of aerial (and ground) robotics
#Alphafold is back in the news with these partnerships of IsoLabs. Drug making away from traditional methods will save research months in both protein structure discovery and the drug development itself. The one challenge/ gap of translating predicted structures into validated drug targets and effective therapeutics is being closed with such thoughtful partnerships. Overall, this truly is a step in the right direction to revolutionize the way humanity discovers and develops new and tailor-speciific drugs into the future. Its impact will likely be felt across various therapeutic areas, leading to faster, more efficient, and potentially more effective drug development for a range of diseases. #multiplesequencealignment #unsupervised #attention #evolutionary #deepmind
It gives me great pleasure to be kicking off 2024 with the first big announcement from Isomorphic Labs that focuses on AI for drug discovery. IsoLabs is now partnering with two of the world’s leading pharmaceutical companies Eli Lilly and Company and Novartis to advance groundbreaking drug-design approaches for the pursuit of new medicines. Isomorphic Labs builds on Google DeepMind’s landmark breakthrough #AlphaFold, which can be used to accurately predict the structure of proteins in the human body, enabling researchers to identify new target pathways to deliver drugs for fighting disease. By combining Google DeepMind’s state-of-the-art AI with the unique strengths of these companies, Isomorphic Labs can accelerate its ability to deliver life-changing medicines for patients. https://lnkd.in/eVJSwkqa